Gracia Porras
Madrid, MD 28040, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Modulation of Mitochondria-Endoplasmic Reticulum Contacts (MERCs) by Small Molecules as a New Strategy for Restoring Lipid Metabolism in an Amyotrophic Lateral Sclerosis Model.
Journal: Journal of medicinal chemistry
Published: January 08, 2025
Proteome Aggregation in Cells Derived from Amyotrophic Lateral Sclerosis Patients for Personalized Drug Evaluation.
Journal: ACS chemical neuroscience
Published: October 14, 2024
Functional Characterization of a Familial ALS-Associated Missense TBK1 (p-Arg573Gly) Mutation in Patient-Derived Lymphoblasts.
Journal: International journal of molecular sciences
Published: December 17, 2022
Discovery of Mitophagy Inhibitors with Therapeutic Potential in Different Familial Amyotrophic Lateral Sclerosis Mutations.
Journal: International journal of molecular sciences
Published: September 29, 2022
Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis.
Journal: Journal of medicinal chemistry
Published: January 05, 2022
Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis.
Journal: International journal of molecular sciences
Published: July 09, 2021
Molecular Alterations in Sporadic and SOD1-ALS Immortalized Lymphocytes: Towards a Personalized Therapy.
Journal: International journal of molecular sciences
Published: February 05, 2021
CdSe Quantum Dots in Human Models Derived from ALS Patients: Characterization, Nuclear Penetration Studies and Multiplexing.
Journal: Nanomaterials (Basel, Switzerland)
Published: January 29, 2021
Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP-43-related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS).
Journal: Journal of neurochemistry
Published: January 08, 2020
Recapitulation of Pathological TDP-43 Features in Immortalized Lymphocytes from Sporadic ALS Patients.
Journal: Molecular neurobiology
Published: May 25, 2018
Leukocyte-endothelial cell interaction is enhanced in podocalyxin-deficient mice.
Journal: The international journal of biochemistry & cell biology
Published: November 06, 2017
Loss of endothelial barrier integrity in mice with conditional ablation of podocalyxin (Podxl) in endothelial cells.
Journal: European journal of cell biology
Published: March 14, 2016
Last Updated: 09/26/2026